EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ATF3 Regulates Osteogenic Function by Mediating Osteoblast Ferroptosis in Type 2 Diabetic Osteoporosis

Yantao Zhao, Yunxia Du, Yijie Gao, Zhijie Xu, Dexiang Zhao, Maowei Yang iD

Disease Markers · 26.10.2022 · 2022 · 1-17

DOI: 10.1155/2022/9872243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Markers, erschienen am 26.10.2022. Verfasst von Yantao Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery, Dalian Municipal Central Hospital, Dalian, Liaoning Province, China. Hauptthemen laut MEDLINE: Ferroptosis, Diabetes Mellitus, Type 2, Osteoporosis. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Guidance Program, Chinese National Natural Science Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Osteoporosis is a complication of type 2 diabetes, and it is characterized by reduced bone mass, augmented bone fragility, and increased risk of fracture, thus reducing patient quality of life, especially in the elderly. Ferroptosis has been implicated in the pathological process of type 2 diabetic osteoporosis (T2DOP), but the specific underlying mechanisms remain largely unknown. This study clarified the role of activating transcription factor 3 (ATF3) in T2DOP and explored its specific regulatory mechanism, providing a new treatment target for T2DOP.

Methods

We cultured hFob1.19 cells in high glucose (HG, 35 mM) and knocked down ATF3 using short hairpin RNA (shRNA). We then measured cell viability, assessed morphology, quantified the expression of ATF3 and glutathione peroxidase 4 (GPX4), detected the levels of reactive oxygen species (ROS) and lipid peroxides, and determined the osteogenic function of osteoblasts. Cystine/glutamate antiporter (system Xc-) activity was evaluated by determining the expression of SLC7A11 and the levels of glutathione (GSH) and extracellular glutamate. We constructed a T2DOP rat model and observed the effect of ATF3 on ferroptosis and T2DOP by knocking down ATF3 using small interfering RNA (siRNA). Then, we evaluated the levels of iron metabolism, lipid peroxidation, and bone turnover in serum, detected the expression of ATF3, SLC7A11, and GPX4 in bone tissues, and assessed bone microstructure using microcomputed tomography.

Results

ATF3 expression was increased in osteoblasts under HG condition and in T2DOP rats. Inhibiting the function of ATF3 increased GPX4 levels and reduced the accumulation of ROS and lipid peroxides. These changes inhibited the ferroptosis of osteoblasts and improved osteogenic function. In addition, HG induced ATF3 upregulation, resulting in decreased SLC7A11 expression and lower levels of intracellular GSH and extracellular glutamate.

Conclusion

Osteoblast ferroptosis under HG conditions is induced by ATF3-mediated inhibition of system Xc- activity, and these events contribute to T2DOP pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisDiabetes Mellitus, Type 2OsteoporosisRatsAnimalsActivating Transcription Factor 3Reactive Oxygen SpeciesLipid PeroxidesX-Ray MicrotomographyQuality of LifeOsteoblastsGlutamates

Substanzen

Activating Transcription Factor 3Reactive Oxygen SpeciesLipid PeroxidesGlutamatesAtf3 protein, rat

Autor:innen und Institutionen

  • Department of Joint Surgery, Dalian Municipal Central Hospital, Dalian, Liaoning Province, China.
  • China Medical University, Shenyang, Liaoning Province, China.
  • Department of Rehabilitation Medicine, The Second Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
  • Dalian Medical University, Dalian, Liaoning Province, China.
  • Department of Orthopedics, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.

ORCID-Profile: Maowei Yang

Förderung

  • National Key R&D Guidance Program
  • Chinese National Natural Science Foundation Project

Zitieren

APA

Zhao, Y., Du, Y., Gao, Y., Xu, Z., Zhao, D., & Yang, M. (2022). ATF3 Regulates Osteogenic Function by Mediating Osteoblast Ferroptosis in Type 2 Diabetic Osteoporosis. Disease Markers, 2022, 1-17. https://doi.org/10.1155/2022/9872243

Vancouver

Zhao Y, Du Y, Gao Y, Xu Z, Zhao D, Yang M. ATF3 Regulates Osteogenic Function by Mediating Osteoblast Ferroptosis in Type 2 Diabetic Osteoporosis. Disease Markers. 2022;2022:1-17. doi:10.1155/2022/9872243

BibTeX
@article{Zhao2022,
  author = {Zhao, Yantao and Du, Yunxia and Gao, Yijie and Xu, Zhijie and Zhao, Dexiang and Yang, Maowei},
  title = {ATF3 Regulates Osteogenic Function by Mediating Osteoblast Ferroptosis in Type 2 Diabetic Osteoporosis},
  journal = {Disease Markers},
  year = {2022},
  volume = {2022},
  pages = {1--17},
  doi = {10.1155/2022/9872243}
}
Kostenlos starten →